Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05179824

Tempus Priority Study: A Pan-tumor Observational Study

Tempus Priority Study: An Observational Study of Patients Who Have Received Comprehensive Genomic Profiling

Status
Active Not Recruiting
Phase
—
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Tempus AI · Industry
Sex
All
Age
—
Healthy volunteers
Not accepted

Summary

Observational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific eligibility criteria outlined for each cohort with the goal of conducting research to advance cancer care and create a dataset that furthers cancer research.

Detailed description

The Study will collect combined clinical and molecular health information for cancer patients in the United States from multiple academic medical centers and community oncology practices. Participants who agree to join the Study will have their molecular profiling results, associated clinical health information, and longitudinal outcomes health information collected by the participating Institution for submission to Tempus. The specific goal of the Study is to create an outcomes-based dataset for future research to improve cancer treatment.

Conditions

Interventions

TypeNameDescription
OTHERObservationNo Intervention

Timeline

Start date
2020-10-19
Primary completion
2026-10-19
Completion
2030-10-19
First posted
2022-01-05
Last updated
2025-05-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05179824. Inclusion in this directory is not an endorsement.